<DOC>
	<DOCNO>NCT02038361</DOCNO>
	<brief_summary>Acute leukemias heterogeneous group malignancy characterize abnormal proliferation cell clone bone marrow , origin lymphocytic myeloid lineage . The repertoire mutation determine leukemic transformation , complex variable depend tumor type progression disease , combine cell balance unbalanced chromosomal aberration , point mutation epigenetic abnormality . The project present part comprehensive approach diagnosis hematologic malignancy child . Using comparative genomic hybridization microarray ( array- CGH ) transcriptome analysis microarray , two innovative technique comprehensive analysis genome transcriptome , offer new perspective identify molecular defect . These technique provide new element identification acute leukemia diagnosis may identify new prognostic factor optimize care patient . This project involve Department Medical Genetics ( Prof. N. LEVY ) regard identification genomic abnormality associate childhood leukemia , Laboratory Hematology Hospital de la Timone ( Prof. Pierre Morange ) term phenotypic characterization tumor cell , Onco - Hematology Pediatric Department ( Prof. Michel Gerard ) provide diagnosis , treatment , monitor bone marrow child hematologic malignancy . The following project mainly focus identification genomic abnormality ( deletion duplication ) abnormality gene expression identify genetic profile ensure good classification within different group risk . The project propose center identification genomic abnormality , change number copy certain region genome determine loss heterozygosity , identification change level gene expression use two analytical technique , comparative genomic hybridization microarray ( array- CGH ) expression study microarrays . The data generate , identification `` molecular signatures `` , classification patient accord prognosis , variation treatment response survival . The originality project lie use new tool diagnosis hematological malignancy child . This pilot study conduct commercial Affymetrix , develop chip ' processing ' , dedicate , enrich probe correspond gene involve leukemogenesis , high discriminatory power identify signature . The data publish specialized literature study large series patient show microarrays provide important information diagnosis therapeutic management patient . It reason end hope integrate analyzes routine diagnosis complement analyzes ( phenotyping , identification fusion gene sequence ) order characterize abnormal cell leukemia establish `` identity card leukemia .</brief_summary>
	<brief_title>Implementation Innovative Techniques Routine Diagnosis Childhood Acute Leukemia : Analysis Genome Transcriptome Micro-array</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<criteria>patient age 018 year diagnosis acute leukemia patient without leukemia diagnosis patient quantity obtain DNA RNA insufficient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>